RU2454996C2 - Применение ксантогумола и изоксантогумола в качестве активного вещества для профилактики и/или борьбы с заболеваниями печени - Google Patents

Применение ксантогумола и изоксантогумола в качестве активного вещества для профилактики и/или борьбы с заболеваниями печени Download PDF

Info

Publication number
RU2454996C2
RU2454996C2 RU2009128213/15A RU2009128213A RU2454996C2 RU 2454996 C2 RU2454996 C2 RU 2454996C2 RU 2009128213/15 A RU2009128213/15 A RU 2009128213/15A RU 2009128213 A RU2009128213 A RU 2009128213A RU 2454996 C2 RU2454996 C2 RU 2454996C2
Authority
RU
Russia
Prior art keywords
xanthohumol
body weight
use according
active substance
day
Prior art date
Application number
RU2009128213/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2009128213A (ru
Inventor
Клаус ХЕЛЛЕРБРАНД (DE)
Клаус ХЕЛЛЕРБРАНД
Original Assignee
Йох. Барт Унд Зон Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Йох. Барт Унд Зон Гмбх Унд Ко. Кг filed Critical Йох. Барт Унд Зон Гмбх Унд Ко. Кг
Publication of RU2009128213A publication Critical patent/RU2009128213A/ru
Application granted granted Critical
Publication of RU2454996C2 publication Critical patent/RU2454996C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3486—Humulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
RU2009128213/15A 2006-12-22 2007-12-21 Применение ксантогумола и изоксантогумола в качестве активного вещества для профилактики и/или борьбы с заболеваниями печени RU2454996C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006062264A DE102006062264A1 (de) 2006-12-22 2006-12-22 Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
DE102006062264.2 2006-12-22

Publications (2)

Publication Number Publication Date
RU2009128213A RU2009128213A (ru) 2011-01-27
RU2454996C2 true RU2454996C2 (ru) 2012-07-10

Family

ID=39186950

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009128213/15A RU2454996C2 (ru) 2006-12-22 2007-12-21 Применение ксантогумола и изоксантогумола в качестве активного вещества для профилактики и/или борьбы с заболеваниями печени

Country Status (7)

Country Link
US (1) US20100029757A1 (cg-RX-API-DMAC7.html)
EP (1) EP2120906B1 (cg-RX-API-DMAC7.html)
JP (1) JP5513126B2 (cg-RX-API-DMAC7.html)
CA (1) CA2672155C (cg-RX-API-DMAC7.html)
DE (1) DE102006062264A1 (cg-RX-API-DMAC7.html)
RU (1) RU2454996C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008077618A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722575B2 (en) 2009-11-26 2020-07-28 Genfit Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
EP2641596B1 (en) * 2009-11-26 2018-05-02 Genfit Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
US9221751B2 (en) 2009-11-26 2015-12-29 Genfit Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
US9358185B2 (en) 2012-06-18 2016-06-07 3M Innovative Properties Company Powder composition for air polishing the surface of hard dental tissue
ES2822575T3 (es) * 2012-07-26 2021-05-04 Arcaini Antonio Usos de composiciones que contienen un extracto tostado y xantohumol
EP2742898A1 (en) 2012-12-17 2014-06-18 3M Innovative Properties Company Powder jet device for dispensing a dental material
US9662180B2 (en) 2012-12-17 2017-05-30 3M Innovative Properties Company Device for dispensing a dental material with locking mechanism
EP2742897A1 (en) 2012-12-17 2014-06-18 3M Innovative Properties Company Nozzle head, hand piece and powder jet device for applying a dental material
JP2018519342A (ja) * 2015-07-02 2018-07-19 フラクサン ゲーエムベーハー ウント コー． カーゲー ホップに基づく物質およびその物質の使用
KR20190099481A (ko) * 2016-12-20 2019-08-27 산토리 홀딩스 가부시키가이샤 이소잔토휴몰을 함유하는 지질 대사 촉진용 조성물
FI3651804T3 (en) 2017-07-11 2023-10-04 Aquanova Ag CELL BILISATE CONTAINING CURCUMINE, BOSWELLIA AND XANTHOHUMOL
FI3820527T3 (en) 2018-07-11 2023-09-28 Aquanova Ag XANTHOHUMOL CELL BILISATE
EP3820527B1 (de) * 2018-07-11 2023-08-23 Aquanova AG Xanthohumol-solubilisat
WO2020031957A1 (ja) * 2018-08-10 2020-02-13 サントリーホールディングス株式会社 腸内環境改善用組成物及び腸内細菌叢改善方法
SG11202100265XA (en) * 2018-08-10 2021-02-25 Suntory Holdings Ltd Composition for promoting uric acid excretion, composition for inhibiting urat1 and composition for lowering blood uric acid level
AU2019317043A1 (en) * 2018-08-10 2021-02-04 Suntory Holdings Limited Composition and method for suppressing increase in blood glucose level
SG11202100258PA (en) * 2018-08-10 2021-02-25 Suntory Holdings Ltd Agent for suppressing microbial growth, method for preventing microbial contamination, and beverage
EP4291307A4 (en) * 2021-02-09 2025-01-22 Oregon State University Xanthohumol derivatives and methods for making and using
CA3225379A1 (en) * 2021-07-09 2023-01-12 Devrim ARAN Prenylated chalcone and flavonoid compositions for use in treating cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2232016C2 (ru) * 1996-08-30 2004-07-10 эНПиэС ФАМЭСЬЮТИКЭЛС, ИНК. Изовалерамид-антиспастическое и противосудорожное средство, экстракт из растения семейства valerianaceae или хмеля - средство для лечения симптома спастичности и способ устранения этого симптома, способ лечения патологии, снимаемой центрально-опосредованным снижением мышечного тонуса

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07285856A (ja) 1994-04-21 1995-10-31 Hoechst Japan Ltd 骨粗鬆症治療剤
WO2001003681A2 (en) 1999-07-08 2001-01-18 Prendergast Patrick T Use of flavones, coumarins and related compounds to treat infections
JP3293601B2 (ja) * 1999-09-03 2002-06-17 松下電器産業株式会社 管球およびその製造方法
EP1666051A3 (en) * 2000-04-10 2009-10-07 Takara Bio, Inc. Remedies
US20040156950A1 (en) * 2001-04-05 2004-08-12 Green Martin Richard Use of hop components in foods
JPWO2003006037A1 (ja) * 2001-07-13 2004-10-28 タカラバイオ株式会社 治療剤
DE10308864B4 (de) 2003-02-28 2007-03-01 Paulaner Brauerei Gmbh & Co. Kg Neues Brauverfahren, damit gebrautes Bier und dessen Verwendung
EP1543834A1 (en) 2003-12-16 2005-06-22 Biodynamics Production of hop extracts having oestrogenic and antiproliferative bioactivity
WO2006099015A2 (en) 2005-03-09 2006-09-21 Cardax Pharmaceuticals, Inc. Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders
JP2006306800A (ja) * 2005-04-28 2006-11-09 Kirin Brewery Co Ltd ファルネソイドｘ受容体活性化剤
EP1909584A4 (en) * 2005-07-29 2010-07-07 Bioactives Inc PRENYLFLAVONOID FORMULATIONS
EP2248532A1 (en) * 2005-08-09 2010-11-10 Metaproteomics, LLP Protein kinase modulation by hops and acacia products cross-reference to related applications
JP5246834B2 (ja) * 2005-12-27 2013-07-24 独立行政法人産業技術総合研究所 アディポネクチン産生強化剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2232016C2 (ru) * 1996-08-30 2004-07-10 эНПиэС ФАМЭСЬЮТИКЭЛС, ИНК. Изовалерамид-антиспастическое и противосудорожное средство, экстракт из растения семейства valerianaceae или хмеля - средство для лечения симптома спастичности и способ устранения этого симптома, способ лечения патологии, снимаемой центрально-опосредованным снижением мышечного тонуса

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
РОЖАНЕЦ В.В. Хмель как компонент пива и биологически активных добавок, применяемых в наркологии. Наркология №11, ноябрь 2005, он-лайн [найдено 13.12.10] [найдено из Интернет] http//www.narkotiki.ru/narcologia_ar_6263.html. ШУЛЬПЕКОВА Ю.О. Флавоноиды расторопши в лечении заболеваний печени, РМЖ Человек и лекарство, 06.03.2004, т. 12, №5, он-лайн [найдено 13.12.10] [найдено из Интернет] http//www.rmj.ru/numbers_28.htm. ЗУЗУК Б.М. Хмель вьющийся, аналитический обзор, Провизор, №14, 2004, он-лайн [найдено 13.12.10] [найдено из Интернет] http://www.provisor.com.ua/archiye/2004/N14/art_25.php. CRISTOBAL L. MIRANDA et al, Prenylflavonoids from Hops Inhibit the Metabolic Activation of the Carcinogenic Heterocyclic Amine 2-Amino-3-methylimidazo[4,5-f]quinoline, Mediated by cDNA-Expressed Human CYP1A2, Drug Metab Dispos. 2000 Nov; №28(11), c.1297-302. он-лайн [найдено 13.12.10] [найдено из Интернет] http://dmd.aspetjournals.org/content/28/ll/1297.long. *

Also Published As

Publication number Publication date
EP2120906B1 (de) 2015-04-22
JP2010513360A (ja) 2010-04-30
DE102006062264A1 (de) 2008-06-26
CA2672155A1 (en) 2008-07-03
EP2120906A1 (de) 2009-11-25
CA2672155C (en) 2013-10-01
RU2009128213A (ru) 2011-01-27
US20100029757A1 (en) 2010-02-04
JP5513126B2 (ja) 2014-06-04
WO2008077618A1 (de) 2008-07-03

Similar Documents

Publication Publication Date Title
RU2454996C2 (ru) Применение ксантогумола и изоксантогумола в качестве активного вещества для профилактики и/или борьбы с заболеваниями печени
CN101278928B (zh) 含左卡尼汀或其衍生物的药物组合物及其用途
JP4312402B2 (ja) 抗うつ剤、抗更年期障害剤、抗老人性痴呆症剤、抗アルツハイマー剤
KR100404303B1 (ko) 올티프라즈의 간섬유화 및 간경화 진행의 예방 및치료제로서의 용도 및 올티프라즈를 주성분으로 함유하는제약 조성물
JP2005239581A (ja) 心筋炎の予防、治療又は改善用組成物
EA016576B1 (ru) Применение сложных эфиров гидроксибензойной кислоты для получения лекарственного средства для предупреждения и лечения папилломавирусной инфекции человека
JP2008266291A (ja) フコイダンを有効成分とする酸性尿改善飲食物および経口投与用医薬組成物
CN105832759A (zh) 一种预防和/或治疗由冠状病毒属和/或轮状病毒属病毒引发的疾病的药物组合物
EP1263435B1 (en) Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
US20080160001A1 (en) Antihypercholesterolemic Formulation with Less Side-Effects
US20140066519A1 (en) Use of xanthohumol and/or isoxanthohumol as an agent for preventing and/or combating liver diseases
JPWO2010087150A1 (ja) 胃酸分泌抑制剤及びカリウムチャンネル阻害剤
TW200803828A (en) Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent
JP2018519342A (ja) ホップに基づく物質およびその物質の使用
CN104758305A (zh) 三七皂苷Ft1的医药用途
KR20010019397A (ko) 발기부전 치료용 조성물
JP2016079163A (ja) 腫瘍を処置するための組成物およびその製造方法
KR100377789B1 (ko) 간섬유화 및 간경화 치료 및 예방용 의약 조성물
US7078045B2 (en) Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
JP2001335503A (ja) ラジカル消去用医薬品
Kashyap et al. Molecular Aspects on Anti-SARS-CoV-2 Activity of Flavonols: Inhibitory on Protein Targets, Immunomodulatory, and Anti-Inflammatory Effects
CN105832714A (zh) 牛磺酸在预防和/或治疗由冠状病毒属和/或轮状病毒属病毒引发的疾病中的应用
JP2004168767A (ja) α−グルコシダーゼ阻害剤
CN105012325A (zh) 三七皂苷st-4的医药用途

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20131023

MM4A The patent is invalid due to non-payment of fees

Effective date: 20171222